Idarucizumab, A specific reversal agent for dabigatran: Mode of action, pharmacokinetics and pharmacodynamics, and safety and efficacy in phase 1 subjects
Reilly, Paul A., van Ryn, Joanne, Grottke, Oliver, Glund, Stephan, Stangier, JoachimLanguage:
english
Journal:
The American Journal of Emergency Medicine
DOI:
10.1016/j.ajem.2016.09.050
Date:
September, 2016
File:
PDF, 902 KB
english, 2016